Cytosorbents Corp (NASDAQ:CTSO)’s traded shares stood at 0.2 million during the last session, with the company’s beta value hitting 1.23. At the close of trading, the stock’s price was $1.09, to imply an increase of 9.00% or $0.09 in intraday trading. The CTSO share’s 52-week high remains $1.61, putting it -47.71% down since that peak but still an impressive 34.86% since price per share fell to its 52-week low of $0.71. The company has a valuation of $68.24M, with an average of 0.19 million shares in intraday trading volume over the past 10 days and average of 118.94K shares over the past 3 months.

Cytosorbents Corp (NASDAQ:CTSO) trade information

After registering a 9.00% upside in the last session, Cytosorbents Corp (CTSO) has traded red over the past five days. The 5-day price performance for the stock is -7.63%, and 9.00% over 30 days. With these gigs, the year-to-date price performance is 55.71%. Short interest in Cytosorbents Corp (NASDAQ:CTSO) saw shorts transact 1.43 million shares and set a 16.43 days time to cover.

CTSO Dividends

Cytosorbents Corp has its next earnings report out on 2025-May-14. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Cytosorbents Corp (NASDAQ:CTSO)’s Major holders

Cytosorbents Corp insiders hold 15.29% of total outstanding shares, with institutional holders owning 27.77% of the shares at 32.78% float percentage. In total, 27.77% institutions holds shares in the company, led by AVENIR CORP. As of 2024-06-30, the company held over 2.97 million shares (or 5.4695% of shares), all amounting to roughly $2.09 million.

The next major institution holding the largest number of shares is SKYLANDS CAPITAL, LLC with 2.84 million shares, or about 5.2311% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $2.0 million.